|
|
|
|
European BioPharm Scale-Up Congress 2008
Conference:
Post-congress briefing
19 Sept 8.30am - 5:30pm
Day 1
17 Sept 8.30am - 5:30pm
Day 2
18 Sept 8.30am - 5:30pm
› Add this to my calendar
› Email a friend
or call +44 (0) 20 7092 1230
|
|
The second European BioPharm Scale-Up Congress was a success, attracting 75 participants with eight sponsors and exhibitors. Of the 75 participants, 40% attended from biotech and pharmaceutical companies, 32% from contract service/research organizations and 3% other.
14 different countries from around the world were represented. 81% of participants came from Europe, 13% from North America & Canada and 6% from the Rest of the World.
› More information |
|
|
And this year's congress will be even bigger
Stay ahead of the market and be pro-active with your bioprocessing strategies
The biologics business is booming. Advances in therapeutic protein, vaccine and antibody development in recent years have revolutionised the biopharmaceutical industry. These products are predicted to be the key industry revenue drivers of the future. The value of the biologics market is expected to reach €68 billion by 2010!
With the upward industry trend showing an increasing need for the production of biopharmaceuticals at consistently higher quality and volumes, the importance of developing an effective and efficient bioprocess has never been more important.
Biomanufacturing has always been integral to the biologic industry growing, allowing it to outpace the pharmaceutical market in terms of sales revenue. But as we enter an age of unprecedented development of biopharmaceutical therapeutics it is not without its challenges. With an increasing demand being placed on a greater number of product classes it is imperative that development and scale-up is fast, efficient and without regulatory issues.
The European BioPharm Scale-Up Congress provides you with the platform to enhance your bioprocessing strategies. It will help you find the solutions to keep your company competitive and allow you to build on your existing knowledge base.
» Download the conference brochure
» Register now
Who should attend?
-
Pharmaceutical manufacturers
-
Biotechs
-
Research institutes
-
Contract manufacturing organisations
-
Contract research organisations
-
Equipment / technology providers
-
Service providers
|
Learn from industry experts
|
What’s in it for you? Are you prepared for the bioprocess revolution?
For biopharmaceutical manufacturers:
- Enhance your product manufacturing capabilities through novel technology implementation and analysis of cutting edge economical strategies
- Determine the in-house and outsourced bioprocessing opportunities that enable enhanced and economical product manufacture
|
For biotechs:
- Compare the strengths and weaknesses of bioprocessing strategies and understand which factors are likely to drive your competitive advantage
- Learn which biologic manufacturing technologies represent the most attractive targets for integration into existing capabilities
- Align your product portfolio capability with bioprocess operational excellence;best position yourself as a future key player in this industry
- Identify alternative channels and sources of bioprocessing and biomanufacture to enable long term strategic goals
|
Network with your industry peers |
Co-location with bioLOGIC Europe
Bringing together representatives from both the technical and strategic corners of the biological market place creates a forum where you will meet a broader cross-section of key industry practitioners and decision-makers in one place.
We have the speakers, the topics and the networking opportunities, so don't delay, book you place today!
|
|
|
|
|
|
|
|
|
|
|
